UK probes Novo Nordisk Ozempic, Saxenda over suicidal, self-harming thoughts Ruchika Sharma27 July 2023 2:30 PM ISTLondon: Britain is reviewing a class of drugs used in a diabetes medicine and a weight-loss treatment sold by Novo Nordisk after some patients...
Sanofi-AstraZeneca Beyfortus gets USFDA nod for protection of infants against RSV disease Ruchika Sharma18 July 2023 11:24 AM ISTParis: The U.S. Food and Drug Administration (FDA) has approved Sanofi and AstraZeneca’s Beyfortus (nirsevimab-alip) for the prevention of...
Sanofi Dupixent gets nod in India for treatment of adults with moderate-to-severe atopic dermatitis Ruchika Sharma11 July 2023 1:12 PM ISTDupilumab is being jointly developed by Sanofi and Regeneron under a global collaboration agreement.
First trial over heartburn drug Zantac cancer claims expected in November Ruchika Sharma3 July 2023 2:30 PM ISTNew York: The first U.S. trial over claims that discontinued heartburn drug Zantac causes cancer is now expected to take place in California state...
CDSCO Panel Approves Sanofi's Protocol Amendment Proposal for SAR443122 Dr. Divya Colin2 July 2023 5:30 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO) has approved the protocol...
Sanofi prevails in Zantac arbitration initiated by Boehringer Ingelheim Ruchika Sharma21 Jun 2023 1:30 PM ISTThere is no evidence of consumer harm from real world use of Zantac as a result of any NDMA contamination.
AstraZeneca-Sanofi Nirsevimab unanimously recommended by USFDA Advisory Committee for prevention of RSV in infants Ruchika Sharma9 Jun 2023 1:30 PM ISTLondon: The US Food and Drug Administration (FDA) Antimicrobial Drugs Advisory Committee (AMDAC) has voted unanimously 21 to 0 that AstraZeneca and...
New Sandoz Board of Directors appointed Ruchika Sharma15 May 2023 2:57 PM ISTBasel: The Novartis Board of Directors has approved the recommendations of the Sandoz Chairman-designate, Gilbert Ghostine, on the structure of the...
Nirsevimab delivers 83 percent reduction in RSV infant hospitalizations in a real world clinical trial setting: Sanofi Ruchika Sharma14 May 2023 2:00 PM ISTRSV is the most common cause of LRTD, including bronchiolitis and pneumonia, in infants.
Sanofi India demerger gets a green light Ruchika Sharma10 May 2023 5:33 PM ISTUpon completion of the proposed demerger, Sanofi will continue to own 60.4 percent stake in both entities and Sanofi India Limited shareholders will...
Sanofi concludes acquisition of Provention Bio Ruchika Sharma28 April 2023 12:30 PM ISTParis: Sanofi has announced the completion of its acquisition of Provention Bio, Inc.. The acquisition adds TZIELD (teplizumab-mzwv), a fully owned,...
Elisabeth Moreno to join Sanofi's Diversity, Equity and Inclusion Board Ruchika Sharma18 April 2023 2:30 PM ISTParis: Sanofi has announced the appointment of Elisabeth Moreno, former French Minister for Gender Equality, Diversity and Equal opportunities, to its...
